33 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
or adjustments; and
delays in necessary interactions with regulators, ethics committees and other important agencies and contractors due to limitations … regulatory authorities, ethics committees, and other governmental entities with respect to clinical trials AMTI conduct or sponsor outside of the U.S
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
in necessary interactions with regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or furlough … materially harm AMTI’s business.
In addition to U.S. regulatory requirements, AMTI is also subject to regulation by foreign regulatory authorities, ethics
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
interactions with regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or furlough … harm AMTI’s business.
In addition to U.S. regulatory requirements, AMTI is also subject to regulation by foreign regulatory authorities, ethics
425
EX-2.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Sep 23
Business combination disclosure
4:28pm
Authorities, Institutional Review Boards and Ethics Committees all required End of Trial notifications for all closed-out studies and clinical trials
8-K
EX-2.1
r7dg4t
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
424B4
juh6etoym
11 Dec 20
Prospectus supplement with pricing info
1:38pm
424B4
n5a867
11 Dec 20
Prospectus supplement with pricing info
12:00am